Dalmia Bharat (DALMIASUG)

Cyclical

FairStock Score: 36/100 — MIXED

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹422.4
Market Cap₹3,418.88 Cr
P/E Ratio16.81
ROCE9.48%
ROE11.08%
Dividend Yield1.42%
Profit Growth-82.1%
Debt/Equity0.56
Sales Growth-10%
Promoter Holding74.91%
52-Week Range₹261.4 — ₹520
SectorAgricultural Food & other Products
Book Value₹396.96

Strengths

Concerns

AI Analysis

When I look at Dalmia Bharat, I remind myself that a good business and a good buy are different things. Sugar is a commodity; the company likely has little pricing power. At ₹399.20, it trades at 7.22 times trailing earnings and 1.04 times book value. That is not an expensive price. The book value of ₹384.21 provides a cushion, and debt/equity of 0.17 tells me the balance sheet is conservative. I like that. Promoter holding at 74.91% also aligns interests. But I cannot ignore the top line. Sales fell 16.70%, while profit rose 17.64%. That kind of divergence usually means costs or other income are helping, not that demand is strong. ROE is 11.08%, and ROCE is 9.48% — acceptable, but hardly a marvellous franchise. The latest quarter had ₹698 Cr in sales and ₹70 Cr net profit. One quarter does not make a trend. The stock trades near the upper end of its 52-week range of ₹261.40 to ₹441.75, so the market has already noticed the earnings recovery. If I call this a wonderful business, I would be fooling myself. It is a cyclical producer selling at a reasonable valuation with a clean balance sheet. The F-Score of 6/9 is mixed, not a strong signal. The dividend yield of 1.99% is modest. Graham taught me to buy with a margin of safety. At P/B of just above book and P/E of 7.22, there is some safety in the numbers. But a commodity business with declining sales and a mixed score of 48/100 does not compel me to be aggressive. I would keep it in the 'too difficult' pile until I see sales growth return and profit quality improve. If the sugar cycle turns, this could work as a value turnaround. But I need more evidence before committing new capital.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer